GASTRIC/GEJ CANCER

Browse all GASTRIC/GEJ CANCER
Ep. 4: Next-Line Strategies and Practice Insights for Durvalumab in Gastric and GEJ Cancer

GASTRIC/GEJ CANCER

Ep. 4: Next-Line Strategies and Practice Insights for Durvalumab in Gastric and GEJ Cancer

Rahul Gosain, MD, MBA, Rohit Gosain, MD, Angela Alistar, MD, Steven Maron, MD, MSc, Reetu Mukherji, MD, Raji Shameem, MD

Ep. 4: Sequencing and Next Steps for Zanidatamab in HER2-Positive Gastric Cancer

GASTRIC/GEJ CANCER

Ep. 4: Sequencing and Next Steps for Zanidatamab in HER2-Positive Gastric Cancer

Rahul Gosain, MD, MBA, Rohit Gosain, MD, Geoffrey Ku, MD, Rutika Mehta, MD, MB, MPH, Manish Shah, MD, Nataliya Uboha, MD, PhD

Ep. 3: Balancing Therapy Intensity and Patient Tolerability in Gastric and GEJ Cancer

GASTRIC/GEJ CANCER

Ep. 3: Balancing Therapy Intensity and Patient Tolerability in Gastric and GEJ Cancer

Rahul Gosain, MD, MBA, Rohit Gosain, MD, Angela Alistar, MD, Steven Maron, MD, MSc, Reetu Mukherji, MD, Raji Shameem, MD

Ep. 3: HERIZON-GEA-01: Infusion and GI Management for Zanidatamab

GASTRIC/GEJ CANCER

Ep. 3: HERIZON-GEA-01: Infusion and GI Management for Zanidatamab

Rahul Gosain, MD, MBA, Rohit Gosain, MD, Geoffrey Ku, MD, Rutika Mehta, MD, MB, MPH, Manish Shah, MD, Nataliya Uboha, MD, PhD